Do Not Stop Levothyroxine - Reduce the Dose Instead
With a suppressed TSH of 0.045 mIU/L, you should not stop levothyroxine but rather reduce the dose by 12.5-25 mcg and recheck thyroid function in 4-8 weeks. This represents overtreatment, not an indication to discontinue therapy entirely 1.
Why Dose Reduction, Not Discontinuation
The FDA label explicitly states that levothyroxine replacement therapy is "generally to be taken for life" 2. Your suppressed TSH indicates you're receiving too much medication, creating a state of iatrogenic subclinical hyperthyroidism, which carries cardiovascular risks—particularly atrial fibrillation in older adults 2.
The Management Algorithm
Step 1: Reduce the current dose
- Decrease by 12.5-25 mcg daily 1
- Smaller adjustments (12.5 mcg) are preferable when fine-tuning to goal TSH
Step 2: Recheck thyroid function
- Wait 4-8 weeks after dose adjustment before retesting 1
- Measure TSH (and free T4 if needed)
Step 3: Target TSH range
- Goal TSH depends on your age and clinical context
- For most adults: TSH 0.4-4.0 mIU/L is appropriate
- If you're over 60: higher TSH targets (up to 7.5 mIU/L for those over 80) may be acceptable 3
Step 4: Continue adjustments
- Make incremental changes every 4-8 weeks until TSH normalizes
- Once stable, monitor TSH every 6-12 months 1
Critical Pitfalls to Avoid
Do not abruptly stop levothyroxine unless you're one of the rare patients who was inappropriately started on therapy. The 2012 AACE/ATA guidelines emphasize that dose adjustments should be gradual and guided by TSH monitoring 1.
Beware of cardiovascular complications from overtreatment: Your suppressed TSH puts you at risk for:
- Atrial arrhythmias (especially atrial fibrillation if elderly) 2
- Increased cardiovascular events
- Bone density loss with chronic suppression
When Discontinuation Might Be Considered
Recent evidence suggests that only in adults ≥60 years taking ≤50 mcg daily should discontinuation even be explored 4. Even then, only 25.7% successfully stopped therapy while maintaining adequate thyroid function. This study found that 63.6% of those on ≤50 mcg could discontinue, but this requires:
- Age ≥60 years
- Low dose (≤50 mcg)
- Supervised, stepwise reduction protocol
- Close monitoring with repeat thyroid function tests
This does not apply to you right now—you need dose optimization, not discontinuation.
The Underlying Principle
Your suppressed TSH means you're getting too much thyroid hormone replacement, but the underlying indication for treatment (hypothyroidism) hasn't disappeared. The solution is recalibration of your dose to achieve physiologic thyroid hormone levels, not abandonment of necessary hormone replacement 2.
If symptoms of hyperthyroidism are present (palpitations, tremor, heat intolerance, weight loss), these reinforce the need for immediate dose reduction 2.